Home » Product » 6-months Outcome of the Effects of Sacubitril/Valsartan Combination in the Treatment of Chronic Heart Failure

6-months Outcome of the Effects of Sacubitril/Valsartan Combination in the Treatment of Chronic Heart Failure

The study included 64 patients over the age of 38 who were treated at the Eurasia Hospital with a diagnosis of CHF. The diagnosis of CHF was confirmed on the basis of anamnesis, objective and instrumental examination methods. Eligibility criteria: history of chronic heart failure; circulatory failure (functional class II-IV, NHYA); left ventricular ejection fraction

ISBN: 9798710608616

23.99

Categories: ,

Additional information

Author

Ulviyya Eyubova

ISBN

9798710608616

Language

Number of pages

39

Publisher

Publication year

Description

The study included 64 patients over the age of 38 who were treated at the Eurasia Hospital with a diagnosis of CHF. The diagnosis of CHF was confirmed on the basis of anamnesis, objective and instrumental examination methods. Eligibility criteria: history of chronic heart failure; circulatory failure (functional class II-IV, NHYA); left ventricular ejection fraction <40%. Exclusion criteria: acute myocardial infarction; hypertrophic cardiomyopathy; congenital heart defects; patients under 25 years of age; heart failure in oncology patients. In order to clarify the diagnosis and monitor the dynamics of the disease, a detailed anamnesis was collected in each patient, 2-dimensional echocardiography and Doppler echocardiography, 6-minute walking test examinations were used to measure the saturation of oxygen in the blood with a pulse oximeter, standard ECG examination, to assess the structural-geometric and functional parameters of the left ventricle of patients and the methods for determining the level of sodium B peptide in the blood were used. ECG, BNP determination, EcoGq, and 6-minute walking test were used to differentiate patients selected for the study based on anamnestic data and clinical signs. In conclusion, we have concluded that the addition of sacubitril / valsartan complex to the treatment of CHF patients is of great important.